Flu Vaccine Offers Moderate Protection From Stroke

WEDNESDAY, Sept. 7, 2022 (HealthDay News) -- Influenza vaccination seems to have a moderate protective effect on ischemic stroke, according to a study published online Sept. 7 in Neurology.
Sara Rodríguez-Martín, Pharm.D., Ph.D., from the University of Alcalá in Madrid, and colleagues conducted a nested case-control study to examine the association between influenza vaccination and risk for a first ischemic stroke during pre-epidemic, epidemic, and postepidemic periods. The source cohort included individuals aged 40 to 99 years with at least one-year registry and no history of stroke or cancer; five controls were randomly selected per case, matched for exact age, sex, and date of stroke diagnosis (index date; 14,322 incident ischemic stroke cases and 71,610 matched controls).
The researchers found that 41.4 and 40.5 percent of the cases and controls, respectively, were vaccinated, yielding a crude odds ratio of 1.05. Vaccinated individuals had a higher prevalence of vascular risk factors, disease, and comedication; after full adjustment, the association of influenza vaccination with ischemic stroke yielded an adjusted odds ratio of 0.88, which appeared early (adjusted odds ratio15 to 30 days, 0.79) and decreased over time (adjusted odds ratio>150 days, 0.92). The reduced risk was of similar magnitude for noncardioembolic and cardioembolic stroke, in all three epidemic periods and in all subgroups.
"These results are yet another reason for people to get their yearly flu shot, especially if they are at an increased risk of stroke," a coauthor said in a statement. "To be able to reduce your risk of stroke by taking such a simple action is very compelling."
Several authors disclosed financial ties to Sanofi.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Was this page helpful?
Related Posts
Iliac Vein Stenting Appears Safe in Office-Based Lab Setting
MONDAY, Feb. 7, 2022 (HealthDay News) -- Iliac vein stenting seems safe in an...
ASCO: Desmoplastic Melanoma Responds to Neoadjuvant Pembrolizumab
TUESDAY, June 7, 2022 (HealthDay News) -- For patients with resectable...
Huge Study Shows Masks Do Indeed Limit Coronavirus Spread
FRIDAY, Sept. 3, 2021 (HealthDay News) -- A new, huge study provides real-world...
Una cirugía mínimamente invasiva podría ser una buena opción en el cáncer de páncreas
VIERNES, 26 de mayo de 2023 (HealthDay News) -- La cirugía mínimamente invasiva...